Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids

Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids

Abstract Objectives To investigate the incidence of active tuberculosis (TB) among COPD patients using fluticasone/salmeterol or budesonide/formoterol, and to identify any differences between these two groups of patients. Methods The study enrolled COPD patients from Taiwan NHIRD who received treatm...

Full description

Bibliographic Details
Main Authors: Tsan-Ming Huang, Kuan-Chih Kuo, Ya-Hui Wang, Cheng-Yi Wang, Chih-Cheng Lai, Hao-Chien Wang, Likwang Chen, Chong-Jen Yu, On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE)
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Infectious Diseases
Subjects:
Fluticasone/salmeterol
Budesonide/formoterol
COPD
Tuberculosis
Online Access:http://link.springer.com/article/10.1186/s12879-020-05440-6

Internet

http://link.springer.com/article/10.1186/s12879-020-05440-6

Similar Items